BioInfra Life Science Inc. (XKON:266470)
South Korea flag South Korea · Delayed Price · Currency is KRW
215.00
+15.00 (7.50%)
At close: Feb 13, 2026

BioInfra Life Science Company Description

BioInfra Life Science Inc., a healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea.

It provides cancer screening test technology service, cancer biomarker research, in-vitro diagnostics medical devices, and targeted drug delivery systems for cancer treatment.

The company was founded in 2001 and is headquartered in Seoul, South Korea.

BioInfra Life Science Inc.
CountrySouth Korea
Founded2001
IndustrySurgical and Medical Instruments and Apparatus
CEODukyun Lee

Contact Details

Address:
66, 1st Building
Seoul
South Korea
Phone82 2 6271 0102
Websitebioinfra.co.kr

Stock Details

Ticker Symbol266470
ExchangeKorea New Exchange
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code3841

Key Executives

NamePosition
Dukyun LeeChief Executive Officer